Clinical Trial Results:
Therapie des nodalen Follikulären Non-Hodgkin-Lymphoms (WHO Grad I/II) im klinischen Stadium I / II mittels involved-field Bestrahlung in Kombination mit Rituximab (Mabthera Involved-field Radiotherapy-Trial/ MIR)
english translation:
Therapy of the nodal follicular non-Hodgkin´s Lymphoma (WHO Grade I/II) in clinical stage I/II with involved field radiatherapy in combination with Rituximab (Mabthera Involved-field Radiotherapy-Trial/ MIR)
Summary
|
|
EudraCT number |
2006-001212-72 |
Trial protocol |
DE |
Global completion date |
10 Apr 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
27 Dec 2019
|
First version publication date |
27 Dec 2019
|
Other versions |
|
Summary report(s) |
MIR summary report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.